Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides

NCT07442630 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Pitavastatin 4mg
DRUG: Ezetimibe 10 mg
DRUG: Placebo (for Pitavastatin/Ezetimibe)
DRUG: Placebo (for Pitavastatin)

Sponsor

JW Pharmaceutical